RANI: Rani Therapeutics Inc Company Aggregate Debts

Symbol and logo of brand ranitherapeutics.com (RANI)

Rani Therapeutics (RANI) staff motivation is tied to option programs for technological breakthroughs. The volume of obligations on the chart serves as a confidence indicator, fixing the metric value at 0.00. The company's pricing power is growing thanks to an innovative robo-capsule that replaces injections. Established reserves of polymers and electronics guarantee production stability, eliminating disruptions in the assembly of delivery systems.

RANI: Rani Therapeutics Holdings Company Debts 07/04/2022 - 10/29/2026

Rani Therapeutics (RANI) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Price Performance Chart ranitherapeutics.com|RANI - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Rani Therapeutics Inc|RANI - Total Company Value
- balance sheet equity data:
Accounting Value of a Share Rani Therapeutics|RANI - Company Book Value|Market Cap to Net Assets Ratio ranitherapeutics.com|RANI - Company Total Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Rani Therapeutics|RANI - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital ranitherapeutics.com|RANI - Company Debts|Debts to Book Value Rani Therapeutics Inc|RANI - Company Long-Term Liabilities|Amount of Current Liabilities Rani Therapeutics
Fundamental company analysis:RANI - Rani Therapeutics Holdings
Signature product of Rani Therapeutics Holdings, Inc.

This indicator reflects the total volume of borrowed obligations, allowing for the real-time tracking of loan procurement and repayment to assess financial stability. Analyzing the debt profile is critically important for Rani Therapeutics (RANI), as controlling capital deposits ensures the seamless scaling of its pill-based injection replacement technology, confirming the strength of the company's fundamental position.

Who Rani Therapeutics competes with

HLN (Haleon Corp) - Aggregate Debt Obligations|Company Aggregate Debts KVUE (Kenvue Inc.)|Company Aggregate Debts veronapharma.com VRNA|MENS - Company Debts|Aggregate Debt Obligations LGND (Ligand Pharmaceuticals Incorporated)|Amneal Pharmaceuticals Inc (AMRX) - Company Debts|Company Total Debt Perrigo Corp|ALVO (Alvotech) - Company Aggregate Debts|Company Aggregate Debts liquidia.com|Company Total Debt GLPG (Galapagos)|ANIP (ANI Pharmaceuticals Inc) - Aggregate Debt Obligations|Company Debts MannKind Corp. MNKD|Amphastar Corp (AMPH) - Company Cumulative Debt|PCRX: Company Total Debt|ars-pharma.com - Company Cumulative Indebtedness|TBPH: Company Aggregate Debts|Aquestive Therapeutics Inc - Aggregate Debt Obligations|SCPH (scPharmaceuticals, Inc.) - Company Aggregate Debts|Company Cumulative Debt Tectonic TECX|Company Debts Tonix Pharmaceuticals (TNXP)|SXTC (sxtchina.com) - Aggregate Debt Obligations|Company Debts Eupraxia Pharmaceuticals Inc. EPRX|Aggregate Debt Obligations BHST|Invizyne Technologies, Inc. - Company Aggregate Debts|ORMP - Company Aggregate Debts|enterabio.com (ENTX) - Company Debts|Company Aggregate Debt HYFT|ABVC (ABVC BioPharma, Inc.) - Company Aggregate Debts|Cumberland Pharmaceuticals Inc (CPIX) - Company Total Debt Obligations|Company Total Debt QNTM (Quantum BioPharma Limited)|FGEN (FibroGen Corporation) - Aggregate Debt Obligations|Telomir Pharmaceuticals - Company Total Debt|Company Cumulative Indebtedness SNYR (Synergy CHC Corp.)|Rallybio Corp. - Company Aggregate Debts|Aggregate Debt Obligations LEXX (Lexaria Bioscience)|PULM: Company Aggregate Debts|Company Cumulative Debt Pheton Holdings (PTHL)|Company Debts Aptorum Group Ltd|LYRA: Aggregate Debt Obligations|Company Aggregate Debts IBO|Company Aggregate Debts tnfpharma.com (TNFA)|Company Debts cbdMD YCBD|PRFX (PainReform Corp) - Company Aggregate Indebtedness|Auris Medical - Company Aggregate Debts|Company Cumulative Debt lipella.com|OPTN (OptiNose) - Company Total Debt|Pieris Pharmaceuticals Inc (PIRS) - Company Aggregate Debts|Company Total Debt PROC|PTPI (Petros Pharma) - Company Cumulative Indebtedness|Company Aggregate Debts QLI|Company Total Debt Obligations acelyrin.com|Company Aggregate Debts TFFP (TFF Pharmaceuticals, Inc.)